Exelixis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. 

CEO
Michael M. Morrissey
CEOMichael M. Morrissey
Employees
1,077
Employees1,077
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
1994
Founded1994
Employees
1,077
Employees1,077

EXEL Key Statistics

Market cap
14.24B
Market cap14.24B
Price-Earnings ratio
18.32
Price-Earnings ratio18.32
Dividend yield
Dividend yield
Average volume
2.03M
Average volume2.03M
High today
$58.51
High today$58.51
Low today
$57.23
Low today$57.23
Open price
$58.33
Open price$58.33
Volume
1.62M
Volume1.62M
52 Week high
$59.72
52 Week high$59.72
52 Week low
$33.76
52 Week low$33.76

Stock Snapshot

As of today, Exelixis(EXEL) shares are valued at $57.43. The company's market cap stands at 14.24B, with a P/E ratio of 18.32.

On 2026-09-11, Exelixis(EXEL) stock traded between a low of $57.23 and a high of $58.51. Shares are currently priced at $57.43, which is +0.3% above the low and -1.8% below the high.

The Exelixis(EXEL)'s current trading volume is 1.62M, compared to an average daily volume of 2.03M.

During the past year, Exelixis(EXEL) stock moved between $33.76 at its lowest and $59.72 at its peak.

During the past year, Exelixis(EXEL) stock moved between $33.76 at its lowest and $59.72 at its peak.

EXEL News

Simply Wall St 14h
Exelixis Stock Looks Undervalued On Earnings But Mixed On Value - simplywall.st

...

Exelixis Stock Looks Undervalued On Earnings But Mixed On Value - simplywall.st
TipRanks 2d
Adagene announces $2M milestone payment from Exelixis

Adagene (ADAG) announced the achievement of a milestone in its ongoing collaboration and license agreement with Exelixis (EXEL). The milestone achievement is re...

Analyst ratings

57%

of 21 ratings
Buy
33.3%
Hold
57.1%
Sell
9.5%

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.